ATE273710T1 - N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung - Google Patents

N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung

Info

Publication number
ATE273710T1
ATE273710T1 AT97903257T AT97903257T ATE273710T1 AT E273710 T1 ATE273710 T1 AT E273710T1 AT 97903257 T AT97903257 T AT 97903257T AT 97903257 T AT97903257 T AT 97903257T AT E273710 T1 ATE273710 T1 AT E273710T1
Authority
AT
Austria
Prior art keywords
cancer metastasis
boxonubicin
acetylcystein
inhibiting cancer
pharmaceutical composition
Prior art date
Application number
AT97903257T
Other languages
German (de)
English (en)
Inventor
Flora Silvio De
Adriana Albini
Original Assignee
Zambon Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Spa filed Critical Zambon Spa
Application granted granted Critical
Publication of ATE273710T1 publication Critical patent/ATE273710T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
AT97903257T 1996-02-14 1997-02-12 N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung ATE273710T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000277A IT1282625B1 (it) 1996-02-14 1996-02-14 Composizione farmaceutica atta ad inibire la formazione di metastasi tumorali
PCT/EP1997/000627 WO1997029759A1 (en) 1996-02-14 1997-02-12 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin

Publications (1)

Publication Number Publication Date
ATE273710T1 true ATE273710T1 (de) 2004-09-15

Family

ID=11373264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97903257T ATE273710T1 (de) 1996-02-14 1997-02-12 N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung

Country Status (7)

Country Link
EP (1) EP0885006B1 (enEXAMPLES)
JP (1) JP2000504704A (enEXAMPLES)
AT (1) ATE273710T1 (enEXAMPLES)
CA (1) CA2245863A1 (enEXAMPLES)
DE (1) DE69730317D1 (enEXAMPLES)
IT (1) IT1282625B1 (enEXAMPLES)
WO (1) WO1997029759A1 (enEXAMPLES)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19926154A1 (de) 1999-06-09 2000-12-14 Ktb Tumorforschungs Gmbh Verfahren zur Herstellung einer injizierbaren Arzneimittelzubereitung
AU2005263729B2 (en) * 2004-07-22 2011-01-06 Bey Pharma GmbH Use of compounds containing thiol groups as an efflux pump inhibitor
AU2008250518B2 (en) 2007-05-16 2013-09-12 Ktb Tumorforschungsgesellschaft Mbh Low-viscous anthracycline formulation
WO2011110838A2 (en) * 2010-03-08 2011-09-15 Procure Therapeutics Limited Differentiation factor

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4331648A (en) * 1979-12-05 1982-05-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services N-Acetyl-cysteine protects against cardiac damage from subsequently-administered cardio-toxic anthra-cycline in cancer therapy
US4873088A (en) * 1983-09-06 1989-10-10 Liposome Technology, Inc. Liposome drug delivery method and composition

Also Published As

Publication number Publication date
EP0885006A1 (en) 1998-12-23
EP0885006B1 (en) 2004-08-18
DE69730317D1 (de) 2004-09-23
IT1282625B1 (it) 1998-03-31
JP2000504704A (ja) 2000-04-18
ITMI960277A0 (enEXAMPLES) 1996-02-14
CA2245863A1 (en) 1997-08-21
ITMI960277A1 (it) 1997-08-14
WO1997029759A1 (en) 1997-08-21

Similar Documents

Publication Publication Date Title
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
IL123889A0 (en) Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
GEP20022784B (en) Celecoxib Composition
GB9401894D0 (en) New compositions of matter
TR200101481T2 (tr) Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi.
MY119403A (en) Novel compounds with analgesic effect.
DE69318503D1 (de) Ein definiertes lipidsystem enthaltende pharmazeutische zusammensetzung
WO2002013873A3 (en) P97-active agent conjugates and their methods of use
DK1126828T3 (da) Oral indgivelse af adenosin-analoger
AU2874099A (en) Low molecular weight compounds administered together with anti-cancer agents to treat cancer and pharmaceutical compositions thereof
DE69434121D1 (de) Pharmazeutische zusammensetzung zur immunstimulierenden therapie
IL150953A0 (en) A composition comprising camptothecin and a pyrimidine derivative for the treatment of cancer
NZ507570A (en) Antitumor composition containing a synergistic combination of an anthracycline derivative with a camptothecin derivate
DE60322454D1 (de) Pharmazeutische Zusammensetzungen zur oralen und topischen Verabreichung
RS49599B (sr) Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija
ATE273710T1 (de) N-acetylcystein und boxonubicin enthaltende pharmazeutische zusammensetzung zur hemmung der krebsmetastasierung
EE04838B1 (et) Interleukiin-18 inhibiitorite kasutamine kasvaja metastaaside pärssimiseks sobivate ravimite valmistamiseks ning selliseid inhibiitoreid sisaldav farmatseutiline kompositsioon
UA37278C2 (uk) Протикашльова фармацевтична композиція для перорального введення
AU4789099A (en) Therapeutic composition based on flavonoids for use in the treatment of tumours with cytotoxic agents
GEP20043225B (en) 1-Trifluoromethyl-4-Hydroxy-7- Piperidinyl-Aminomethylchroman Derivatives
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug
DK0927031T3 (da) Farmaceutisk sammensætning indeholdende nimesulid til oral admnistration
IL147901A0 (en) Phenanthroline-7-one derivatives and their therapeutic uses
DE69918124T2 (de) Zusammensetzungen und Vorrichtungen zur transdermalen Verabreichung von Fenoldopam
IT1211748B (it) Composizioni farmaceutiche ad atti vita'antineoplastica

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties